Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: A randomized placebo-controlled trial

Journal of the American Medical Directors Association

Volumn 12, Issue 9, 2011, Pages 639-647

  Lackner, Thomas E ^a   Wyman, Jean F ^b   McCarthy, Teresa C ^c   Monigold, Melinda ^b   Davey, Cynthia ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aged; Anticholinergics; Efficacy, cognition; Urinary incontinence

Indexed keywords

OXYBUTYNIN; PLACEBO;

ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MINI MENTAL STATE EXAMINATION; NURSING HOME PATIENT; PATIENT COMPLIANCE; PATIENT MOBILITY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; UNSPECIFIED SIDE EFFECT; URGE INCONTINENCE; URINARY FREQUENCY; URINARY TRACT INFECTION; URINARY URGENCY;

EID: 82455172095     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.05.003     Document Type: Article

References (25)

1. Resnick N.M., Yalla S.V., Laurino E. The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med 1989, 320:1-7.
2. Ouslander J.G., Uman G.C., Urman H.N., Rubenstein L.Z. Incontinence among nursing home patients. Clinical and functional correlates. J Am Geriatr Soc 1987, 35:324-330.
3. Burgio K.L., Locher J.L., Goode P.S., et al. Behavioral vs drug treatment for urge incontinence in older women. A randomized controlled trial. JAMA 1998, 280:1995-2000.
4. Tannenbaum C., DuBeau C.E. Urinary incontinence in the nursing home: practical approach to evaluation and management. Clin Geriatr Med 2004, 20:437-452.
5. Schnelle J.F., Cruise P.A., Rahman A., Ouslander J.G. Developing rehabilitative behavioral interventions for long-term care: Technology transfer, acceptance, and maintenance issues. J Am Geriatr Soc 1998, 46:771-777.
6. Narayanan S., Cerulli A., Kahler K.H., Ouslander J.G. Is drug therapy for urinary incontinence used optimally in long-term care facilities?. J Am Med Dir Assoc 2007, 8:98-101.
7. Ouslander J.G., Schnelle J.F., Uman G., et al. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents?. J Am Geriatr Soc 1995, 43:610-617.
8. Ouslander J.G., Blaustein J., Connor A., Pitt A. Habit training and oxybutynin for incontinence in nursing home patients. J Am Geriatr Soc 1988, 36:40-46.
9. Ouslander J.G., Maloney C., Grasela T.H., et al. Implementation of a nursing home urinary incontinence management program with and without tolterodine. J Am Med Dir Assoc 2001, 2:207-214.
10. Chapple C.R., Khullar V., Gabriel Z., et al. The effects of antimuscarinic treatments in overactive bladder: An update of a systemic review and meta-analysis. Eur Urol 2008, 54:543-562.
11. Lackner T.E., Wyman J.F., McCarthy T.C., et al. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc 2008, 56:862-870.
12. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
13. Schnelle J.F., Newman D.R., Fogarty T. Statistical quality control in nursing homes: Assessment and management of chronic urinary incontinence. Health Serv Res 1990, 25:627-637.
14. Schnelle J.F. Managing Urinary Incontinence in the Elderly 1991, Springer Publishing, New York.
15. Morris J., Murphy D., Nonemaker S. Long-Term Care Resident Assessment Instrument User's Manual Version 2.0 1995, Health Care Financing Administration, Baltimore, MD.
16. Morris J.N., Fries B.E., Mehr D.R., et al. Development of a MDS Cognitive Performance Scale. J Gerontol 1994, 49:174-182.
17. Ouslander J.G., Schnelle J.F., Uman G., et al. Predictors of successful prompted voiding among incontinent nursing home residents. JAMA 1995, 273:1366-1370.
18. Ouslander J.G., Ya-Chen T.S., Malone-Lee, Luber K. Overactive bladder: Special considerations in the geriatric population. Am J Manag Care 2000, 6:S599-S606.
19. Dmochowski R.R., Nitti V., Staskin D., et al. Transdermal oxybutynin in the treatment of adults with overactive bladder: Combined results of two randomized clinical trials. World J Urol 2005, 23:263-270.
20. Burgio K.L., Locher J.L., Goode P.S., et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998, 280:1995-2000.
21. Burgio K.L., Locher J.L., Goode P.S. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 2000, 48:370-374.
22. Zinner N., Gittelman M., Harris, et al. Trospium chloride improves overactive bladder symptoms: A multicenter phase III trial. J Urol 2004, 171:2311-2315.
23. Chapple C.R., Rechberger T., Al-Shukri S., et al. Randomized, double-blind, placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 2004, 93:303-310.
24. 3 selective receptor antagonist. Eur Eurol 2005, 48:471-477.
25. Zinner N.R., Mattiasson A., Stanton S.L. Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc 2002, 50:799-807.